4712 related articles for article (PubMed ID: 24556840)
1. Molecular mechanisms of epithelial-mesenchymal transition.
Lamouille S; Xu J; Derynck R
Nat Rev Mol Cell Biol; 2014 Mar; 15(3):178-96. PubMed ID: 24556840
[TBL] [Abstract][Full Text] [Related]
2. The Post-Translational Regulation of Epithelial-Mesenchymal Transition-Inducing Transcription Factors in Cancer Metastasis.
Kang E; Seo J; Yoon H; Cho S
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808323
[TBL] [Abstract][Full Text] [Related]
3. Mnt Represses Epithelial Identity To Promote Epithelial-to-Mesenchymal Transition.
Lavin DP; Abassi L; Inayatullah M; Tiwari VK
Mol Cell Biol; 2021 Oct; 41(11):e0018321. PubMed ID: 34460331
[TBL] [Abstract][Full Text] [Related]
4. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition.
Moes M; Le Béchec A; Crespo I; Laurini C; Halavatyi A; Vetter G; Del Sol A; Friederich E
PLoS One; 2012; 7(4):e35440. PubMed ID: 22514743
[TBL] [Abstract][Full Text] [Related]
5. TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops.
Zhang J; Tian XJ; Zhang H; Teng Y; Li R; Bai F; Elankumaran S; Xing J
Sci Signal; 2014 Sep; 7(345):ra91. PubMed ID: 25270257
[TBL] [Abstract][Full Text] [Related]
6. A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors.
Ohashi S; Natsuizaka M; Naganuma S; Kagawa S; Kimura S; Itoh H; Kalman RA; Nakagawa M; Darling DS; Basu D; Gimotty PA; Klein-Szanto AJ; Diehl JA; Herlyn M; Nakagawa H
Cancer Res; 2011 Nov; 71(21):6836-47. PubMed ID: 21890822
[TBL] [Abstract][Full Text] [Related]
7. Cytoskeletal signaling in TGFβ-induced epithelial-mesenchymal transition.
Nalluri SM; O'Connor JW; Gomez EW
Cytoskeleton (Hoboken); 2015 Nov; 72(11):557-69. PubMed ID: 26543012
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism involved in epithelial to mesenchymal transition.
Jayachandran J; Srinivasan H; Mani KP
Arch Biochem Biophys; 2021 Oct; 710():108984. PubMed ID: 34252392
[TBL] [Abstract][Full Text] [Related]
9. Role of the epithelial-mesenchymal transition and its effects on embryonic stem cells.
Kim YS; Yi BR; Kim NH; Choi KC
Exp Mol Med; 2014 Aug; 46(8):e108. PubMed ID: 25081188
[TBL] [Abstract][Full Text] [Related]
10. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
Saitoh M
Cancer Sci; 2015 May; 106(5):481-8. PubMed ID: 25664423
[TBL] [Abstract][Full Text] [Related]
12. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition.
Gregory PA; Bracken CP; Smith E; Bert AG; Wright JA; Roslan S; Morris M; Wyatt L; Farshid G; Lim YY; Lindeman GJ; Shannon MF; Drew PA; Khew-Goodall Y; Goodall GJ
Mol Biol Cell; 2011 May; 22(10):1686-98. PubMed ID: 21411626
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.
Lin CY; Tsai PH; Kandaswami CC; Lee PP; Huang CJ; Hwang JJ; Lee MT
Cancer Sci; 2011 Apr; 102(4):815-27. PubMed ID: 21219539
[TBL] [Abstract][Full Text] [Related]
14. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
[TBL] [Abstract][Full Text] [Related]
15. The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC).
Wang Y; Wu Z; Hu L
Eur J Pharmacol; 2018 Sep; 834():45-53. PubMed ID: 30017802
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination.
Lu M; Jolly MK; Levine H; Onuchic JN; Ben-Jacob E
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18144-9. PubMed ID: 24154725
[TBL] [Abstract][Full Text] [Related]
17. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism.
Mikaelian I; Malek M; Gadet R; Viallet J; Garcia A; Girard-Gagnepain A; Hesling C; Gillet G; Gonzalo P; Rimokh R; Billaud M
Cancer Res; 2013 Nov; 73(22):6621-31. PubMed ID: 24078802
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
19. Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition.
Kolesnikoff N; Attema JL; Roslan S; Bert AG; Schwarz QP; Gregory PA; Goodall GJ
J Biol Chem; 2014 Apr; 289(16):11194-11205. PubMed ID: 24627491
[TBL] [Abstract][Full Text] [Related]
20. TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition.
Shirakihara T; Horiguchi K; Miyazawa K; Ehata S; Shibata T; Morita I; Miyazono K; Saitoh M
EMBO J; 2011 Feb; 30(4):783-95. PubMed ID: 21224849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
